ACTIVE Injection Kit – M includes the active ingredients Marcaine and Methylprednisolone, together with all the components necessary to prepare a sterile intramuscular or intra-articular injection. Marcaine delivers hours of pain relief, while Methylprednisolone controls inflammation and pain associated with many different health conditions including arthritis, bursitis, polymyositis, and systemic lupus erythematosus. Methylprednisolone is also recommended for treating exacerbations of enteritis and ulcerative colitis
Pharmaceutica North America serves as one of the nation’s leading compounding pharmaceutical companies. Our ACTIVE Injection Kit – M offers the cost-effective benefit of a single dose of pre-measured ingredients and reduced preparation time thanks to the convenience of including the syringe, needles, and supporting components in one package. All of our products offer the quality that comes from being manufactured and distributed in accordance with cGMP at an FDA and DEA registered facility.
Approved and Potential Uses of Methylprednisolone and Marcaine Injection:
Methylprednisolone is a potent synthetic glucocorticoid that modifies the immune response and inhibits inflammation by controlling the rate of protein synthesis, suppressing migration of polymorphonuclear leukocytes, stabilizing lysosomes and reversing capillary permeability.
Marcaine (bupivacaine) is an amide-type local anesthetic with onset in 20 to 30 minutes and duration of about 8 hours, which is longer than other commonly used local anesthetics. It blocks pain signals by reducing the flow of sodium and increasing action potential threshold.
Methylprednisolone and Marcaine may be injected using intramuscular, intra-articular, soft tissue, or intralesional routes. Consider using the ACTIVE Injection Kit – M for the following conditions:
Rheumatic disorders – As adjunctive therapy for acute episode or exacerbation in rheumatoid arthritis (including juvenile arthritis), osteoarthritis, ankylosing spondylitis, psoriatic arthritis, acute rheumatic carditis, gouty arthritis, acute, and subacute bursitis, nonspecific tenosynovitis, epicondylitis and synovitis, systemic lupus erythematosus, dermatomyositis, and polymyositis.
Dermatologic diseases – Bullous dermatitis herpetiformis, exfoliative erythroderma, severe erythema multiforme, pemphigus, and mycosis fungoides.
Ophthalmic diseases – Uveitis, temporal arteritis, sympathetic ophthalmia, and ocular inflammatory conditions unresponsive to topical corticosteroids.
Allergic conditions – To control severe allergic conditions unresponsive to conventional treatment in asthma, atopic dermatitis, contact dermatitis, seasonal allergic rhinitis, drug hypersensitivity reactions, serum sickness, and transfusion reactions.
Endocrine disorders – To treat primary or secondary adrenocortical insufficiency, hypercalcemia associated with cancer, nonsuppurative thyroiditis, and congenital adrenal hyperplasia—use in conjunction with mineralocorticoids where applicable.
Gastrointestinal conditions – To relieve acute flare-ups of ulcerative colitis and regional enteritis.
Respiratory diseases – Used concurrently with antituberculous chemotherapy for fulminating or disseminated pulmonary tuberculosis.
Renal disease – Used to induce diuresis or remission of proteinuria due to lupus erythematosus or idiopathic nephrotic syndrome.
Hematologic disorders – For rare conditions such as acquired hemolytic anemia, pure red cell aplasia, and Diamond-Blackfan anemia.
Components Included in the ACTIVE Injection Kit – M:
When you purchase the ACTIVE Injection Kit – M from Pharmaceutica North America, you gain a team of experts prepared to answer questions, ensure you have vital pharmaceuticals, and help you navigate the supply chain. Contact us today to learn about our fast shipping and to experience first-class customer service in action.